Non-invasive Prediction of EArly Cardiac rEjection

Part of paid clinical trials in Little Rock, Arkansas.

Sponsor
Vanderbilt University Medical Center
Study ID
NCT07770659
Status
Recruiting

Conditions

  • Cardiac MRI
  • Cell Free DNA
  • Heart Transplant
  • Pediatric Heart Transplant
  • Rejection

Eligibility Criteria

Sex
ALL
Age
6 Years - 25 Years
Healthy Volunteers
Not accepted

Study Details

Acute rejection remains a major cause of morbidity and mortality in pediatric patients after heart transplant. In order to screen for rejection, most centers perform heart catheterizations with endomyocardial biopsies frequently in the first year post transplant and then every 1-2 years thereafter; these biopsies are associated with complications, can cause significant anxiety in patients and family members, and are a significant cost for the healthcare system. This project will evaluate non-invasive methods of detecting rejection using cardiac magnetic resonance imaging and blood testing with a goal to reduce the required number of cardiac catheterizations.

Key Dates

First listed
Aug 18, 2026
Start date
Mar 29, 2023
Status verified
Jun 2026
Primary completion
Feb 1, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Healthy pediatric heart transplant recipients
    Pediatric heart transplant recipients not having rejection
  • Arm: Pediatric heart transplant recipients with acute rejection
    Pediatric heart transplant recipients with acute rejection (ACR or AMR) as defined by the the core pathologist.
  • Arm: Healthy controls
    Healthy control patients retrospectively enrolled at each site to standardize parametric mapping.

Primary Outcome Measure

Acute rejection [ Time Frame: time of enrollment ]

Central Contacts

Locations (22)

FacilityCityStateZIPSite coordinators
Arkansas Children's HospitalLittle RockArkansas72202
Study Coordinator
501-364-4000
Children's Hospital of Los AngelesLos AngelesCalifornia90027
Study Coordinator
323-361-2461
UCLALos AngelesCalifornia90095
Study Coordinator
310-267-7667
Lucile Packard Children's Hospital at StanfordPalo AltoCalifornia94304
Study Coordinator
650-337-3766
Rady Children's HospitalSan DiegoCalifornia92123
Study Coordinator
858-966-5855
Children's Hospital ColoradoDenverColorado13123
Study Coordinator
720-777-6820
University of FloridaGainesvilleFlorida32608
Study Coordinator
(352) 273-7770
Joe DiMaggio Children's HospitalHollywoodFlorida33021
Study Coordinator
954-265-3437
Children's Hospital of AtlantaAtlantaGeorgia30322
Study Coordinator
404-256-2593
Lurie Children's HospitalChicagoIllinois02115
Study Coordinator
312-227-4000
Riley Children's HospitalIndianapolisIndiana46202
Study Coordinator
317-944-8906
Boston Children's HospitalBostonMassachusetts02115
Study Coordinator
617-355-6000
University of MichiganAnn ArborMichigan48109
Study Coordinator
734-764-5176
Washington UniversitySt LouisMissouri63110
Study Coordinator
314-454-6095
Columbia UniversityNew YorkNew York10032
Study Coordinator
212-305-4432
Mount Sinai Kravis Children's HospitalNew YorkNew York10029
Study Coordinator
212-241-9500
Nationwide Children's HospitalColumbusOhio43205
Study Coordinator
614-722-2530
Vanderbilt University Medical CenterNashvilleTennessee37232
Study Coordinator
Texas Children's HospitalHoustonTexas77030
Study Coordinator
832-824-3278
UT Health HoustonHoustonTexas77030
Study Coordinator
713-486-6755
Seattle Children's HospitalSeattleWashington98105
Study Coordinator
206-987-2000
Medical College of WisconsinMilwaukeeWisconsin53226
Study Coordinator
414-266-6457

Find similar trials in Little Rock, AR

Related Studies